<?xml version='1.0' encoding='UTF-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta id="journal-meta-6869ef86b672428e86eb98c981a6216e">
      <journal-id journal-id-type="nlm-ta">Sciresol</journal-id>
      <journal-id journal-id-type="publisher-id">Sciresol</journal-id>
      <journal-id journal-id-type="journal_submission_guidelines"/>
      <journal-title-group>
        <journal-title>Journal of Pharmaceutical Research</journal-title>
      </journal-title-group>
      <issn publication-format="electronic">2454-8405</issn>
      <issn publication-format="print"/>
    </journal-meta>
    <article-meta id="article-meta-01e8b63cf04848f888bdc60aaafd70fe">
      <article-id pub-id-type="doi">10.18579/jopcr/v22.3.23.43</article-id>
      <article-categories>
        <subj-group>
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title id="article-title-acbe8febeed14d2f8fe3576e92c9106e">
          <bold id="strong-eaea7273e4b04601a13c896f85ebeded">A Review on 1,2,3 - Triazole &amp; Piperazine Derivatives </bold>
          <bold id="strong-8fb56458f786449fad3360b3d3e01054">with Various Biological Activities</bold>
        </article-title>
        <alt-title alt-title-type="right-running-head">A Review on 1,2,3 - Triazole &amp; Piperazine Derivatives</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name id="name-bbcdfa18ad824db18ecabff3bd0709e7">
            <surname>Loganathan</surname>
            <given-names>C Geethapriya</given-names>
          </name>
          <email>geethavaishu2009@gmail.com</email>
          <xref id="xref-10bd82d3df6944f6834aeb3d64d8a8cc" rid="aff-2c4a207796b640df86c4631d2aa232e2" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-25913b01e07241949d57d93bf68875b0">
            <surname>Krishnan</surname>
            <given-names>Karthickeyan</given-names>
          </name>
          <xref id="x-20158b542d7d" rid="a-b4c81bf84ac1" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-e62155a556fc43ba960a245cb992b015">
            <surname>Vachala</surname>
            <given-names>S D</given-names>
          </name>
          <xref id="x-4c0087d583d8" rid="aff-837743c09bb241c29a4d9ce751187bce" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-771e4cdb032f47559948cbccdc87c9d0">
            <surname>Urolagin</surname>
            <given-names>Deeparani</given-names>
          </name>
          <xref id="x-fd9bae0d6c17" rid="a-3d67546b57bb" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-2dd3f71b00b14d75acfed4175f63601c">
            <surname>Vijayakumar</surname>
            <given-names>J</given-names>
          </name>
          <xref id="x-e9774fe4262e" rid="a-1678aa55dbbe" ref-type="aff">5</xref>
        </contrib>
        <aff id="aff-2c4a207796b640df86c4631d2aa232e2">
          <institution>Research scholar, Department of Pharmaceutical Chemistry, VISTAS</institution>
          <addr-line>Chennai, ­600043</addr-line>
        </aff>
        <aff id="a-b4c81bf84ac1">
          <institution>Professor and Head, Department of Pharmacy Practice, VISTAS</institution>
          <addr-line>Chennai, 600043</addr-line>
        </aff>
        <aff id="aff-837743c09bb241c29a4d9ce751187bce">
          <institution>Professor and Head, Department of Pharmaceutical Chemistry, RR College of Pharmacy</institution>
          <addr-line>Bangalore, ­560090</addr-line>
        </aff>
        <aff id="a-3d67546b57bb">
          <institution>Professor and Head, Department of Pharmacology, RR College Of Pharmacy</institution>
          <addr-line>Bangalore, 560090</addr-line>
        </aff>
        <aff id="a-1678aa55dbbe">
          <institution>Asstistant Professor, RR College of Pharmacy, Department of Pharmacology</institution>
          <addr-line>Bangalore, 560090</addr-line>
        </aff>
      </contrib-group>
      <pub-date date-type="pub">
        <day>30</day>
        <month>12</month>
        <year>2023</year>
      </pub-date>
      <volume>22</volume>
      <issue>3</issue>
      <fpage>113</fpage>
      <permissions>
        <copyright-year>2023</copyright-year>
      </permissions>
      <abstract id="abstract-abstract-title-72efa60bb4244b17bf568b9210635f85">
        <title id="abstract-title-72efa60bb4244b17bf568b9210635f85">Abstract</title>
        <p id="paragraph-7162637d6a004c0c9e7fc84261bd5895">The largest family of organic molecules in organic chemistry are heterocyclic compounds. A heterocyclic compound is created when an oxygen, nitrogen, sulphur, or atom of a similar element is included in place of a carbon atom. Heterocyclic compounds play a crucial role in daily living. It has a wide scope of uses in agrochemicals and medicinal chemistry. One of a pair of chemical compounds known as triazoles and Piperazine, with the molecular formula C2H3N3 and C5H5N. A fundamental aromatic heterocyclic scaffold is 1,2,3-triazole and piperazine. Because of its structural characteristics, these moiety’s are valuable in material science and due to its extensive application in chemistry, these can also be synthesized from readily available compounds. This literature review sheds light on the fact that 1,2,3-triazole and piperazine of hetero compounds are profoundly receptive and are known to possess potent diverse activities like, analgesic, anti-HIV, antimalarial, antiviral, anti-inflammatory, anticancer, antibacterial, antifungal, anthelmintic, and so forth. In conclusion numerous biological actions of the Piperazine and 1,2,3-Triazole derivatives of heterocyclic compounds were detailed and reviewed in this review.</p>
        <p id="p-8c42f7b84e73"><bold id="s-c0ec7de0c302">Keywords:</bold> 1,2,3 - Triazole; Biological activities; Piperazine; Anticancer Activity</p>
      </abstract>
      <kwd-group id="kwd-group-d726bcd1e3924c4b8736d210d8a11ff1">
        <title>Keywords</title>
        <kwd/>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title id="title-9ef13e8e5f884274bf9668a924e88851">Introduction</title>
      <p id="paragraph-5e2d332628924206b54cd99c5bd26df1">The most unpredictable aspects of chemistry are often referred to as heterocyclic chemistry, and heterocyclic molecules hold vital significance for medical chemistry <xref id="xref-1189307fcdb44d2ab33d2225e33ab20b" rid="R218357329794903" ref-type="bibr">1</xref>. Heteroatoms are the names for the Sulfur, Nitrogen, and Oxygen found in heterocyclic compounds. They play important roles in the drug development process <xref id="xref-d61b4c27800941ed81b5cda37872c9ce" rid="R218357329794854" ref-type="bibr">2</xref>. These compounds, particularly those with 5 and 6 members, have drawn the attention of the pharmacy network over the years due to their potential for treatment <xref id="xref-bae576dc57ac4ea693f4325ea9dc4eb1" rid="R218357329794864" ref-type="bibr">3</xref>, and they are also lavishly used as intermediates in organic synthesis <xref rid="R218357329794905" ref-type="bibr">4</xref>, <xref rid="R218357329794882" ref-type="bibr">5</xref>, <xref rid="R218357329794850" ref-type="bibr">6</xref> and the synthetic routes are observed by the biological assessment of heterocycles containing nitrogen, sulphur, and oxygen <xref rid="R218357329794867" ref-type="bibr">7</xref>, <xref rid="R218357329794908" ref-type="bibr">8</xref>, <xref rid="R218357329794869" ref-type="bibr">9</xref>, <xref rid="R218357329794897" ref-type="bibr">10</xref>, <xref rid="R218357329794879" ref-type="bibr">11</xref>, <xref rid="R218357329794875" ref-type="bibr">12</xref>, <xref rid="R218357329794866" ref-type="bibr">13</xref>. Azole subsidiaries have been utilized in the plant security innovation as pesticides. To specifically control the development of weeds, an extensive variety of azole herbicides have been fostered that are displaying 1,2,3 triazole heterocyclic blends are known to have extreme activities like antimicrobial <xref rid="R218357329794878" ref-type="bibr">14</xref>, <xref rid="R218357329794860" ref-type="bibr">15</xref> anticonvulsant <xref id="xref-7d53f31a94de48ae9ca2fc49b2eaf8b1" rid="R218357329794880" ref-type="bibr">16</xref>, anti-inflammatory <xref id="xref-fa6ad410a7fe4a7aa7fbfed4566ef82a" rid="R218357329794859" ref-type="bibr">17</xref> , analgesic <xref id="xref-630a59b45acd4d40b0fc1e0be059698d" rid="R218357329794859" ref-type="bibr">17</xref> , antifungal <xref id="xref-416eb63297b2414b9f13ffbda35e9193" rid="R218357329794890" ref-type="bibr">18</xref> anthelmintic <xref rid="R218357329794906" ref-type="bibr">19</xref>, <xref rid="R218357329794894" ref-type="bibr">20</xref> anti-alzheimer’s <xref id="xref-b30dcbc7be054dbdb04b861906a3128b" rid="R218357329794849" ref-type="bibr">21</xref> , anti-plasmodial <xref id="xref-df7cdcb932204c86856052cd2d615f67" rid="R218357329794887" ref-type="bibr">22</xref>  , antituberculosis <xref id="xref-ecb7cb7e147548849304819af5d8820b" rid="R218357329794873" ref-type="bibr">23</xref> , anti-malarial <xref id="xref-ea48f5369062451b975862bd96f7a5a0" rid="R218357329794896" ref-type="bibr">24</xref>, anti-HIV <xref id="xref-6a88b1335bcd4fecb76e21bd41c1b0c1" rid="R218357329794901" ref-type="bibr">25</xref>, and anti-cancer <xref rid="R218357329794861" ref-type="bibr">26</xref>, <xref rid="R218357329794904" ref-type="bibr">27</xref>, <xref rid="R218357329794858" ref-type="bibr">28</xref>, <xref rid="R218357329794883" ref-type="bibr">29</xref>, <xref rid="R218357329794884" ref-type="bibr">30</xref> activity and so forth. By using 1,2,3 triazole and Piperazine derivatives as a starting point, the ongoing. </p>
      <list list-type="bullet">
        <list-item id="li-7a4693343576">
          <p>high level of activity </p>
        </list-item>
        <list-item id="li-616930b68e61">
          <p>application flexibility </p>
        </list-item>
        <list-item id="li-39e4d5fcaddc">
          <p>crop tolerance </p>
        </list-item>
        <list-item id="li-f98ea9ae5a42">
          <p>low levels of toxicity to mammals </p>
        </list-item>
      </list>
      <p id="paragraph-d62d2f8717b849ffaf6ab96c1f8dec56">Concentrate successfully portrays a study on heterocyclic compounds displaying different biological action. </p>
    </sec>
    <sec>
      <title id="title-e440a8e68fcf42cc9fa3061d6036bb88">Pharmacological Activities</title>
      <sec>
        <title id="title-735ea2ef618b42efac63393b91cd73f1">Anti-Microbial activity</title>
        <p id="paragraph-5ffc611e677743f7b8505068e5aaa159">Lima-Neto RG <xref id="xref-c9351d35193a40909ce9c65ccde82e0f" rid="R218357329794892" ref-type="bibr">31</xref> described a series of 1,2,3-triazole analogues with 10 particular The triazole ring's N-1 substitutes were mixed. 4(a-j), and their antifungal activity was assessed. A total of 42 pathogenic kinds of four different Candida species were tested using all of the mixes. The insignificant inhibitory fixation values are significantly impacted by substituent changes because we can obtain triazole subordinates with no antimycotic movement, moderate antifungal action, and one particle with magnificent action. The results of the antifungal tests reveal that the chloro-substituted triazole subordinate specifically exhibited significant contagious development resistance, indicating that additional adjustments to the 2-(1-aryl-1H-1,2,3-triazol-4-yl) series should make it possible to obtain more powerful models.</p>
        <fig id="figure-50cc6ed00d11435597bea9bd30c9d987" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 1 </label>
          <caption id="caption-eca42f23d4304dddaa2d368e70bd8651">
            <title id="title-5d8f3a6fbc64499d8f7c90ab30ba2441"><bold id="strong-ab64a095a14c4214ba1595dbc9181e9b"/>1,2,3-triazole analogues</title>
          </caption>
          <graphic id="graphic-294b7b5965844048980611b6a614dc39" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage1.png"/>
        </fig>
        <p id="paragraph-130c8130c6944ac5864a12abb6b7cb07">Liu T, Weng Z <xref id="xref-660a147bfdd944c39ba9a236d4e6032d" rid="R218357329794862" ref-type="bibr">32</xref> used the bioisosteric-replacement concept and a fragment-assembly approach, a novel series of piperazine derivatives were created 9(a-h). when the cytotoxicity and CCR5-mediated fusion activities of the target drugs were evaluated. Compound 23 h was evaluated with an IC50 value of 6.29 M as a CC5 antagonist and an IC50 value of 0.44 M as an antiviral agent. The Piperazine compounds created in this study and the SAR that resulted may be useful for further optimisation on the path to developing brand-new CCR5 antagonists for the treatment of HIV.</p>
        <p id="p-f6f9139549a4"/>
        <fig id="f-0896fb4e7949" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 2 </label>
          <caption id="c-b309675b45b4">
            <title id="t-1b22b3d7a0bd">Piperazine Derivatives</title>
          </caption>
          <graphic id="g-2ca186fbe916" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/c7a60e73-56dd-44d0-b35c-a728753a96e2-uimage.png"/>
        </fig>
        <p id="p-5394b8b5f1da"/>
        <p id="paragraph-d13e3a6053454ebf9423f0a5f4031db5">Wang BL <xref id="xref-dcb223d10cc64b00be54261a79c01f92" rid="R218357329794872" ref-type="bibr">33</xref> Synthesized the Mannich reaction of 1,2,4-Triazole thiol intermediates comprising 1,2,3-triazole with different subbed piperazines and formaldehyde, a number of novel 1,2,4-triazole thione derivatives including 1,2,3-triazole and substituted piperazine moieties were produced in high yields 9(a-h). Melting points, IR, 1H NMR, 13C NMR, and elemental analyses were used to confirm the structures. The results of the bioassay revealed that some of the compounds have significant fungicidal activities at 50 mg/mL against a variety of plant fungi. In particular, the trifluoromethyl containing triazole thione derivative have broad activities and may benefit from further underlying advancement for novel fungicide advancement research.</p>
        <p id="p-b4b570c17df6"/>
        <fig id="f-07df6437661b" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 3 </label>
          <caption id="c-2ee9240108c6">
            <title id="t-a0950936364c"><bold id="s-04e58a8e0b0a"/>1,2,3-triazole and substituted piperazine moieties</title>
          </caption>
          <graphic id="g-bd0f2674e4b5" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/5650d71d-9e75-4688-931a-321797624ae0-uimage.png"/>
        </fig>
        <p id="p-457c7f7f2a72"/>
        <p id="paragraph-1b28d3977de8429588a165f89a2fa6f9">Jadhav RP <xref id="xref-03bf80b865f549c9a4d275f554910bcd" rid="R218357329794907" ref-type="bibr">34</xref> Incorporated two new series of unique compounds, 5-(substituted phenyl)-1,3,4-Oxadiazol-2-yl and 5-(alkylthio)-1,3,4 – Oxadiazol-2-yl, were synthesized 9(a-e). By using 1H NMR, 13C NMR, and mass spectrum analysis, synthesised compounds were examined for their antibacterial properties. It's interesting to note that the majority of the compounds show moderate to good activity against tested fungal and bacterial strains as well as Gram-positive and Gram-negative bacterial strains. </p>
        <fig id="figure-107b9133c01042fda768d08248810090" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 4 </label>
          <caption id="caption-fba17719cb534c72a6f2f37d7224fceb">
            <title id="title-4eff1a5fccc347c5accab210d8d807f1"><bold id="strong-86f17fcdb0e94bdfb7b8f4a858df8335"/>Piperazine Carboxamides</title>
          </caption>
          <graphic id="graphic-d9c60ce05d6d4c958c82ef0de096e618" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage8.png"/>
        </fig>
        <p id="paragraph-81d35cd3c92f4ddc9e6a354cd1bcd559">Wang Y <xref id="xref-006b8a2c9fa241a89343ea247aaa1a2b" rid="R218357329794886" ref-type="bibr">35</xref> had synthesized triazole with piperazine side chains. The synthesis has demonstrated the use of click chemistry based on the cytochrome P450 14-demethylase active site (CYP51). In order to describe their structures, 1H-NMR, 13C-NMR, MS, and IR were used. Eight human pathogenic fungi were used to investigate the effects of the piperazine moiety on in vitro antifungal activity of all the target compounds.</p>
        <fig id="figure-22bae1e5af894a4aa472a3efb5d3ae9c" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 5 </label>
          <caption id="caption-019a73b473d74161aebee9bc6865963a">
            <title id="title-f39d7a9bfcb04922ad0779df38cc68ce">Piperazine side chains analogues </title>
          </caption>
          <graphic id="graphic-f2a2a609ed4143bca9f6abddd5df901f" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage9.png"/>
        </fig>
        <p id="paragraph-011c976b6a884c529d0aba9d732dfb55">Danne AB <xref id="xref-40fe1195b5084754b77c68b155b15ac5" rid="R218357329794848" ref-type="bibr">36</xref> He discussed the plan of a little library of novel 1,2,3-triazole-appended bis-pyrazoles utilising a Molecular hybridization  method (a-i). <italic id="e-d9f0228da5c0">Aspergillus niger, Aspergillus fumigatus, Candida albicans, Cryotococcus neoformans, Candida glabrata, Candida tropicalis</italic>, and other fungal strains were examined for their antifungal efficacy using the synthesised hybrids. All of the compounds demonstrated good minimum inhibitory concentration values and broad-spectrum action against the tested fungi strains. The molecular docking research against sterol 14-demethylase (CYP51) may offer important information about the binding affinities and mechanisms of these substances. These substances' antioxidant activity was also examined, and the results were likewise encouraging.</p>
        <fig id="figure-e6e03ccc5dc74b01aef0ef4233cc8b5f" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 6 </label>
          <caption id="caption-2c3f34088c944ad48e65cdcac29437f6">
            <title id="title-20fac10056d845bf878a398765a63861"><bold id="strong-1947471702454c00a81cad9372659d25"/>1,2,3-triazole-appended bis-pyrazoles</title>
          </caption>
          <graphic id="graphic-0e74de74f73b45bc8cf301608b7692d7" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage10.png"/>
        </fig>
        <p id="paragraph-d78d640b4cdd475c9629413125e53871">Chen QM <xref id="xref-7b623fee705443da84086ee9e37c167b" rid="R218357329794902" ref-type="bibr">37</xref> Synthesized a potential anticancer and antibacterial medicines, fifteen new dithiocarbamate-derived naphthalimides were created and characterised using spectral and analytical methods. By using X-ray crystallography, the structure of 2b,5a and 7b were established. The MTT technique was used to assess their <italic id="e-51e9a41a562b">in vitro</italic> anticancer activity against MDA-MB-231, HepG-2, PC12, and A549. With an IC50 of 10.86 M, compound 7c with a morpholinyl substituent demonstrated the maximum activity and selectivity for HepG- 2 cancer cells according to the results of the MTT testing. The antibacterial activity of each novel chemical was tested against <italic id="e-e4a8f11aa66f">C.albicans, E.coli, B.substilis, S.aureus</italic>. A minimal inhibitory concentration value were revealed in the results, that compound 7d (an n-methyl piperazine) had high activity against <italic id="e-1651292fc82a">B.subtilis</italic>.</p>
        <fig id="figure-343f6f8baa55498e80d7ee97feedeaed" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 7 </label>
          <caption id="caption-2d8488dd6f8248e89fc5697dd5e15c35">
            <title id="title-964697dbbfd74481beb16913995d0925"><bold id="strong-4337dc0abbe147c8b96ff59919ec076b"/>1, 2, 3-triazole-dithiocarbamate-naphthalimides</title>
          </caption>
          <graphic id="graphic-4935039172d545c0a32ddae088387253" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage11.png"/>
        </fig>
        <p id="paragraph-4bbc9f7af557415281efb21aa98bd5b3">Sriram D et al., <xref id="xref-ecfd49d1682241c888b908e6870bc266" rid="R218357329794909" ref-type="bibr">38</xref> Formaldehyde, secondary amines, and aryl substituted piperazines were combined to create microwave-aided efavirenz Mannich base derivatives. The blends were tested <italic id="e-0d5c452691d4">in vitro</italic> for their ability to fight against HIV and mycobacteria. Among these, fluroquinolone-containing drugs were discovered to be difficult to use and (4i) restricted to <italic id="e-f8c358199575">M. tuberculosis</italic> with the most diminished inhibitory obsession.</p>
        <p id="p-7e7f5432c57b"/>
        <fig id="f-6ef7133de61e" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 8 </label>
          <caption id="c-c3501e25bd49">
            <title id="t-ccaca54f9b46">Efavirenz Mannich bases &amp; derivatives</title>
          </caption>
          <graphic id="g-00eaef981eb6" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/c21903bf-2901-499e-8d68-3a1141bad642-uimage.png"/>
        </fig>
        <p id="p-36c902b35869"/>
        <p id="paragraph-9b5e420bd84247d6a26b3cec31443d8a">Bogdanov AV et al.,<xref id="xref-6bd5bf0dc09e41d3949f932d9a3c7a21" rid="R218357329794857" ref-type="bibr">39</xref> synthesized formaldehyde, isatin and monosubstituted piperazines were synthesised using the Mannich reaction. They were then changed into derivatives of iso indigo. The structures were verified by analytical and spectral data, and their antibacterial activity was then assessed.</p>
        <fig id="figure-e155cd1c24b04c72a28c866d4221c1f6" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 9 </label>
          <caption id="caption-8e8b36dbd09c41d7b4494a4af1e42cbe">
            <title id="title-2d4b231eb2fe4fac89a30fa6c938a676">Piperazine Derivatives</title>
          </caption>
          <graphic id="graphic-3a367acba7c641cd8122319b49575b26" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage16.png"/>
        </fig>
        <p id="paragraph-cb9ae1b574d240abb0ad535249706903">Paneth A et al.,<xref id="xref-db93e7bd250143119577671ee73e345f" rid="R218357329794889" ref-type="bibr">40</xref> Integrated a number of novel Mannich bases were created and their <italic id="e-41384f04098c">in vitro </italic>antibacterial activity was assessed. The findings suggested that for piperazine to have antibacterial action, a phenyl ring appears to be required in position 4 of the compound.</p>
        <p id="paragraph-443183ba545044f78329ac11627d9610">Isloor AM et al., <xref id="xref-ed13f16b913d403e9b09a6e740735e3c" rid="R218357329794856" ref-type="bibr">41</xref> Produced novel Mannich base derivatives by amino methylating 4-(3-substituted 1H -pyrazol-3-yl) methyl amino-5-substituted 4H-1,2,4-triazole-3-thiols (3) with formaldehyde and N-methyl Piperzine. 4- (3-substituted 1H-pyrazol-4-yl)-methyl amino] - 5 - 2-[(4-methylpiperzine-1-yl) methyl] substituted from 1,2,4-triazoles, -2H-1,2,4-triazole-3(4H)-thione is produced. These recently connected structures were seen by 1H NMR, mass, and IR spectra, and their antibacterial and antifungal activity was assessed. When compared to regular compound, blends 4c, 4e, 4h, and 4k showed higher obstruction.</p>
        <fig id="figure-d3676fddf9ea4ad0b1366d11237483e3" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 10 </label>
          <caption id="caption-581dae0be7304f05bf5f86c95afae523">
            <title id="title-54582cf67ce045958424687657bf44f8"><bold id="strong-d6be0273490e4fe5b76596c2cef09b57"/>Novel Mannich base derivatives</title>
          </caption>
          <graphic id="graphic-ab047f4e38ab487da14b34ebfb52ee63" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage17.png"/>
        </fig>
        <p id="paragraph-08b066092ae844178470274330022544">Amani AM et al., <xref id="xref-58cc8bd7c44447b780c5ef000ea4100d" rid="R218357329794855" ref-type="bibr">42</xref> Created a fresh piperazine phenothiazine derivatives. Elemental analysis, FT-IR, (1)H- and 13C-NMR, and Mass Spectroscopy were used to determine the structures of the produced compounds. By using the cup plate, disc diffusion, and Lowenstein-Jensen medium procedures, the compounds' antibacterial, antifungal, and antitubercular activity was assessed, respectively. All the substances shown effective antibacterial action.</p>
        <p id="paragraph-eb72fbe5af024e9d8aa7c2321f5ac59a">Tan W<bold id="strong-7d99b4bc01f54710a72c86bb9f52a09d"> </bold>et al., <xref id="xref-fcbbf772e6ce43a191bb5d4dc142ed8d" rid="R218357329794877" ref-type="bibr">43</xref> Synthesized four new Starch-liked-1,2,3-Triazole derivatives, a six-hydroxymethyltriazole-6-deoxy starch (HMTST), six-bromomethyltriazole -6-deoxy starch (BMTST), six-chloromethyltriazole-6-deoxy starch (CMTST), and six-carboxyltriazole-6-deoxy starch. They were tested <italic id="e-4f05a062c815">in vitro</italic> for their antibacterial efficacy against <italic id="e-143cde3be3c4">E. coli</italic> and <italic id="e-cacdcc8cf26e">S. aureus</italic>, respectively. The developed amphiprotic starch derivatives significantly outperformed starch in terms of their inhibitory properties. And when the culture times were 8 hours and 16 hours, respectively, the antibacterial indices of the majority of the products were greater than 60% and 40% at 1.0 mg/mL. Additionally, at 1.0 mg/mL, the inhibitory index of CBTST reached 97% higher. The inhibitory action generally declined in the following order: CBTST&gt;CMTST&gt;BMTST&gt;HMTST&gt; starch. Additionally, the sequence in which they exhibited antibacterial action was compatible with the ability of various subbed gatherings of the 1,2,3-triazole gatherings. </p>
        <p id="paragraph-dd2fd587486f46ed8b869a4fec9d60cf">Gan LL et al., <xref id="xref-fe4a494585d742ec94f2147e7d5b6eb8" rid="R218357329794876" ref-type="bibr">44</xref> Synthesized a new diphenyl Piperazine 1,2,3-triazole derivatives. The synthesised compounds' were examined for <italic id="e-1fb0e645b8b5">in vitro</italic> antibacterial, antifungal, and cytotoxic properties. According to preliminary findings, Nitroimidazole Piperazine were only moderately affected by <italic id="e-e96a99df6e34">Candida albicans</italic> and <italic id="e-ed01425013d8">Saccharomyces cerevisiae</italic>, whereas <italic id="e-294981ccee21">B.subtilis, Micrococcus luteus, B.proteus, E.coli,</italic> and <italic id="e-68ce7870a5ba">B.typhi </italic>were all substantially affected. Furthermore, it was demonstrated that the 1,2,3-triazole-linked nitroimidazole piperazine compound and benzimidazole piperazine compound were efficient<italic id="e-e511cf3235b3"> in vitro</italic> against the PC-3 cell line, at a concentration of 100 M. The nitro and hydroxyl groups of chemicals may also be able to insert into base pairs of DNA hexamer duplexes by forming hydrogen bonds with DNA's guanine, according to molecular docking investigations.</p>
        <fig id="figure-b7f00dfcc2eb4929bf228ea260dd5131" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 11 </label>
          <caption id="caption-d53f381dd0ae497384ed393b04d5b33c">
            <title id="title-76366b643e40488591bd48e3580442a9"><bold id="strong-72c15ea2044b406eadff49d09e569724"/>Diphenyl piperazine 1,2,3-triazole derivatives</title>
          </caption>
          <graphic id="graphic-eefff27bd2144004a06a6e789a1f68d7" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage18.png"/>
        </fig>
        <p id="paragraph-eb373fb656c045048e3291320b7dab70">Thriveni KS et al., <xref id="xref-8f1a6c6515314c41b2e16fbf4b8f99d7" rid="R218357329794898" ref-type="bibr">45</xref> Synthesised 4-substituted 2-(4-phenylpiperazin-1-yl)-6-(thiophen-2-yl) pyrimidines (5a-e). The newly synthesised compounds 4b, 4d, 5a, and 5b all exhibited strong antibacterial activity at a concentration of 40 g/ml, and 4a, 4d, 4e, 5c, and 5e had effective antifungal activity at a concentration of 40 g/ml.</p>
        <p id="paragraph-6e279023961c402aa5d62b515bd32764"/>
        <fig id="f-645a36d50978" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 12 </label>
          <caption id="c-05001300bc5b">
            <title id="t-22aa3c4209ed">Pyrimidine incorporated piperazine derivatives</title>
          </caption>
          <graphic id="g-a2e063d7566e" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/80ce030c-1a16-474e-8e31-55dd622f9309-uimage.png"/>
        </fig>
        <p id="p-a9109759d465"/>
        <p id="p-26cc288d06b4">Tamer El Malah et al.,<xref id="xref-0ece18db1126410ca43290f2b88ccf88" rid="R218357329794871" ref-type="bibr">46</xref> Cu(I)-catalyzedazide-alkyne cycloaddition with a variety of alkyne-functionalized sugars producedsix novel aryl-subbed 1,2,3 triazoles connected to sugar units with an end goal to create naturally dynamic antibacterial and antifungal medicationsnoval subsidiaries were affirmed utilizing various spectroscopic procedures. New 1,2,3-triazoles' <italic id="e-cb4895bbf666">in vitro </italic>protection from Gram-positive <italic id="e-24a5d4a1ba55">S.aureus</italic> and Gram-negative <italic id="e-3d90d42664c1">P. aeruginosa</italic> was compared with the movement of the standard antibiotic niger was investigated using the drug "Nystatin" as a model and as a reference. <italic id="e-e8e9a0244fad">Staphylococcus aureus</italic> was found to be more susceptible to each of the chemicals under investigation than the other microorganisms under investigation, according to the results of the biological evaluation. A portion of the substances that were inspected likewise showed positive antifungal movement.</p>
        <p id="p-7ddd474c5720"/>
        <fig id="f-285456fd9208" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 13 </label>
          <caption id="c-93576c8a1e32">
            <title id="t-107f6027f42d">Aryl-substituted-1,2,3-triazoles</title>
          </caption>
          <graphic id="g-63c5421d52da" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/65964e13-bd18-46e8-b630-68765715fce1-uimage.png"/>
        </fig>
        <p id="p-65d5f5eb505b"/>
      </sec>
      <sec>
        <title id="t-d534b6c9c984">Analgesic activity</title>
        <p id="p-47e6087fa985">Shantaram Gajanan Khanage <xref id="x-e729f01e06d2" rid="R218357329794851" ref-type="bibr">47</xref> pain-relieving activity was shown by chloropain-relieving movement was shown by dimethylamino, furan, and phenyl subbed subordinates in the two methodologies. The compounds IIIa, IIId, IIIf, IIIi, IIIj, IVa, IVb, IVd, IVf, IVh, IVj, IV3a, and IIj were found to be superior analgesics after being screened using the acetic acid-induced writhing method. Compounds IIIb, IIId, IIIf, IIIh, IIIj, IVa, IVb, IVd, IVf, IVh, IVi, IV3c, IV3e, and IIj demonstrated their potential as analgesics after being tested on a hot plate. Pyrimidine, tetrazole, isoxazole, and all 1,2,4-triazole-containing compounds tested were found to be effective analgesics; consequently, this activity may be supported by these compounds.</p>
        <p id="paragraph-80904f3058f440e19896237a0f5c6074"> </p>
        <fig id="f-9256952b1fe9" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 14 </label>
          <caption id="c-cde5ca7063d0">
            <title id="t-313652eda25a"><bold id="s-da1be9769d54"/>1,2,4 triazole clubbed with heterocyclic Componds</title>
          </caption>
          <graphic id="g-fc7de0c7aa37" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/2c366ab0-3776-4b83-a6f2-21a7a5953fc6-uimage.png"/>
        </fig>
        <p id="p-72c9e23caae3"/>
      </sec>
      <sec>
        <title id="t-b88d1752bb6e">Antioxidant activity</title>
        <p id="p-e9673b08ad94">Josefa  Lima et al ., <xref id="xref-004166f4cd18420380b5a1e6d4e6bba6" rid="R218357329794885" ref-type="bibr">48</xref>  He created a novel class of 1,4-disubstituted 1,2,3-triazoles, and their antioxidant activity is described in this study. These chemicals were produced semi-synthetically by using the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction between ethyl 2-azidoacetate and terminal acetylenes taken from the natural products carvacrol, eugenol, isovanillin, thymol, and vanillin. He got 50-80 % yield, and the structures were confirmed by spectrographic characterisation. Antioxidant activity (ABTS) was measured using 2,2-diphenyl-1-picryhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid). Among the 1,4-disubstituted 1,2,3-triazoles produced, ethyl 2-(4-(4-formyl-2-methoxyphenoxy)methyl)-1H-1,2,3-triazol-1-yl) acetate had the highest antioxidant capacity (EC50 = 75.5 g/mL). The antioxidant activity of the products was only moderate. </p>
        <p id="p-53d25fe24b4e"/>
        <fig id="f-3600b129d504" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 15 </label>
          <caption id="c-66d5c211864c">
            <title id="t-4e6b02126da8"><bold id="s-dbefefdc5583"/>1,4-disubstituted 1,2,3-triazole derivatives</title>
          </caption>
          <graphic id="g-38a1512fe92a" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/f18275e4-0a94-4df8-a870-52ba6dece9cf-uimage.png"/>
        </fig>
        <p id="p-a362b78cc5ca"/>
        <p id="paragraph-a7103a8411524efeac4110e75ced3fbb">Sánchez JS et al., <xref id="xref-b3f5c45de29a4d13980c6f96b2429abf" rid="R218357329794900" ref-type="bibr">49</xref> Novel 1-benzyl-1,2,3-triazole were synthesized and tested for poisoning, cancer prevention, and antibacterial activity with salt water shrimp and the stock microdilution method. Although <italic id="e-be42b51b906e">Escherichia coli</italic> AO11, E. coli AO15, and <italic id="e-b628bbe7b413">Salmonella enterica serovar Typhi</italic> were also immune to a similar effect, the substance 1-(1-Benzyl-1H-1,2,3-triazol-4-yl) cyclopentanol had no effect on Staphylococcus aureus . 5g-I compounds displayed the most severe DPPH• examination venging. The evaluation of manufactured 1,2,3-triazole intensifies arrangements that range from moderately harmful to harmless.</p>
        <fig id="figure-4f9fb5596a7b4a6f8e272951140da921" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 16 </label>
          <caption id="caption-dfa402bd4ea543da87589a3752097169">
            <title id="title-74c62213792f487fac7f31e6ff258175"><bold id="strong-8735d9b81abd4846a120eaa4d65e88d8"/>1-benzyl-1,2,3-triazoles</title>
          </caption>
          <graphic id="graphic-c814fbc6caec48aaa0b15ae132039cd1" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage47.png"/>
        </fig>
        <p id="paragraph-ed22e7eea5f4406a9e6f62bfd3f7c616">Deshmukh TR et al.,<xref id="xref-68a354f4443b4cb78d2b3f2ace3bfe43" rid="R218357329794863" ref-type="bibr">50</xref> Unique piperazine-tethered dimeric 1,2,3-triazoles were synthesized by combining piperazine and 1,2,3-triazoles within a single molecular architectural framework. By 1,3-dipolar cycloaddition of 1,4-di(prop-2-yn-1-yl)piperazine (1) and various azides, the named compounds (3a-m) were produced in high yields. All of the produced compounds (3a-m) have been tested for their <italic id="e-eece7bab0891">in vitro</italic> antitubercular, antifungal, and antioxidant activity against their respective strains. Three of them, 3b, 3d, and 3i, have demonstrated encouraging antitubercular efficacy against <italic id="e-0699783688d3">Mycobacterium tuberculosis </italic>(Mtb) H37Rv with a MIC of 12.5 g/mL. The findings of molecular docking (InhA) provided a firm foundation for these compounds' binding to the Mtb enoyl reductase active site. In addition, it was demonstrated that the majority of synthetic chemicals may have antifungal and antioxidant properties.</p>
        <fig id="figure-b43e4893e19846c8a75bafbf23195097" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 17 </label>
          <caption id="caption-d28d8863f0474daab53b95e5df3e82cb">
            <title id="title-05a3241375be409eac0f383267e73412">New piperazine and amide linked dimeric 1, 2, 3-triazoles</title>
          </caption>
          <graphic id="graphic-1ea7fd55016243d4b22519423736eb36" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage48.png"/>
        </fig>
      </sec>
      <sec>
        <title id="title-e4effd6a7c2c4579adcd17fb73019c16">Anthelmintic activities</title>
        <p id="paragraph-523b9ef17ef548aaac873721afc09886">Gupta JK et al., <xref id="xref-6845172168154611a50187f5b82b5bd6" rid="R218357329794874" ref-type="bibr">51</xref> Investigated for antibacterial ,antifungal , and Antihelmintic activity . In that T71, T73, and T75 all shown antibacterial activity, and T71 further exhibited antifungal action. To explore their vermifuge and vermicidal impact, the mixtures were regulated to <italic id="e-83ce1c6dae89">Pheretima posthuma</italic> at differed portions. The activity of the triazole when combined with 1-methylpiperazine was found to be comparable to that of reference standards. Triazoles are a group of antifungal agents that work well. In this investigation, the chemical T71 demonstrated positive antibacterial and antihelminthic activity.</p>
        <fig id="figure-84766506d8e64d23974de71b794c0f4e" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 18 </label>
          <caption id="caption-b921c14cc2e1455086a0b4b0a2a4702e">
            <title id="title-2a38a82554a54af1927a64ac843af3bc">Triazole Derivatives</title>
          </caption>
          <graphic id="graphic-526b2d7ebc3f4b8cb37b7090d65369c9" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage49.png"/>
        </fig>
        <p id="paragraph-3b19b9572c464a94ad012a4efd9548ba">Madhu Kumar Dogganal<bold id="strong-5986ea5354df429ab440dedc71177b6d"> </bold>Jayappa et al., <xref id="xref-af2ebde618bd4380a60e525a0b3e31ef" rid="R218357329794852" ref-type="bibr">52</xref>  The synthesis of -thione (6a-e) and (7a-h) involved by treating formaldehyde and various substituted primary/secondary amines with 3-methyl-1H-1,2,4-triazole 5(4H)-thione. Synthesized new Mannich bases (E) - -4-((3,4-((3,4-dimthoxybenzyliden) amino). The Schiff base was made by combining 3-methyl-4-amino-5-mercapto-1,2,4-triazole (3) and 3,4-dimethoxybenzaldehyde with an acid catalyst. The triazole (3) was made by combining acetic acid (1) with thio-carbohydrazide (2) at reflux temperature. Spectroscopy was used to investigate the compounds' for antibacterial and antihelminthic properties.</p>
        <fig id="figure-fb3f8a27776046689bd4db811e63bd21" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 19 </label>
          <caption id="caption-ba0552b5346f484d981d837eea280873">
            <title id="title-ab44c0b5f9ba408cb58607c0223e5fd0">Novel Triazole Schiff and Mannich Bases</title>
          </caption>
          <graphic id="graphic-ec9a5ab3065c4b579de0412e94c4019c" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage50.png"/>
        </fig>
      </sec>
      <sec>
        <title id="title-09554ede98e840e8a31216ae6d3c2d27">Anti-diabetic activity</title>
        <p id="paragraph-0d7f3eafcf2f4157bebbef07884f644e">Dastjerdi<bold id="strong-883feaad589f4b1cb213ebd129020d3c"> </bold>et al., <xref id="xref-8e5bafd99fe2408c8383f3f0353a05ac" rid="R218357329794865" ref-type="bibr">53</xref> The inhibitors of the dipeptidyl peptidase type 4 (DPP-4) enzyme, which is a potent activator of insulin production and an inhibitor of glucagon secretion from the pancreas, have been proposed as a promising class of drugs for the treatment of type 2 diabetes mellitus. A new class of 1, 2, 3-triazole-5-carboximidamide subordinates were tested for their ability to inhibit the DPP-4 protein in this study. Compounds 6a, 6b, and 6c specifically demonstrated helpful DPP-4 inhibitory action with respective IC50 values of 14.75nM, 6.75nM, and 6.57nM. At a dose of 10 mg/kg, compound 6a improved glucose resistance in NMRI mice during the oral glucose tolerance test (OGTT).</p>
        <fig id="figure-428d60202c2f4359b9a0d42a3a2c7860" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 20 </label>
          <caption id="caption-28881ab2fb5d4b8b9e67f5c9042903de">
            <title id="title-9bc938ddf801449e86c30f81696f0270"/>
          </caption>
          <graphic id="graphic-b2ae6b87532e4331b0ae0aca4a9d5355" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage51.png"/>
        </fig>
      </sec>
      <sec>
        <title id="title-8b292221b16448e6bcb600e5654649dd">Anticholinesterase activities</title>
        <p id="paragraph-32e0c601c906466ba4c813e0ec289513">Faraz KM<bold id="strong-791352e7f417489ca44fcffd908d4fe8"> </bold>et al., <xref id="xref-10b1c545b2904597a86e9499d18be38d" rid="R218357329794893" ref-type="bibr">54</xref> Investigated the derivatives of hydrazine. A series of eleven new mixtures of N′-(2,4-disubstitutedbenzylidene)- 2-(4-nitrophenyl) acetohydrazide subordinates were delivered by the reaction of 2-[4-(4-nitrophenyl)piperazin-1-yl] acetohydrazide with fragrant aldehydes. The spectral data from HRMS (ESI) and FT-IR, 1H-NMR, 13C-NMR, and ESI were used to clarify the chemical structures of the compounds. Compound 3c was found to be the most active derivative of the chemicals examined, and its efficacy against AChE and BuChE was quantified and evaluated using a modified version of Ellman's spectrophotometric method. Galantamine was a drug that was frequently prescribed.</p>
        <fig id="figure-c3090524865149a88d5944dc78c37dfe" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 21 </label>
          <caption id="caption-5091281db3434618a34f67ed0eec5335">
            <title id="title-968b9f68ae094a3a9f0651f638eeed60"><bold id="strong-90cef56559c64225a408e146dad1751a"/>Hydrazone Derivatives</title>
          </caption>
          <graphic id="graphic-5aebf78f97fb4032bf30fd4732c1cb53" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage52.png"/>
        </fig>
      </sec>
      <sec>
        <title id="title-f86e9bb99889487da5842067485e6e3b">Anti-inflammatory activity</title>
        <p id="paragraph-cd2a134c587d44ac990b244785f49aa7">Shalom Pôrto<bold id="strong-b9af5b859b734524bcd9d9238fc4ae83"> </bold>et al., <xref id="xref-493a4c894517403f846e0e9c315bbbed" rid="R218357329794895" ref-type="bibr">55</xref> Developed four novel, potently anti-inflammatory 1,2,3-triazole phthalimide derivatives. The calming movement was discovered by injecting carrageenan into the plantar tissue of the right rear paw of Swiss white mice to cause irritation. The mixtures 3b and 5c uncovered to have the option to lessen carrageenan-actuated edema in mice by 69% and 56.2%, separately. Every single one of the compounds 3a-c and 5a-c had a significant anti-inflammatory effect. As new anti-inflammatory medications in the future, these substances may also hold promise.</p>
        <fig id="figure-0ddf4ee2b5d94b27b410de369816d2f2" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 22 </label>
          <caption id="caption-dffe5900b8404f8daf9cf8884b24da6f">
            <title id="title-2dfe37f5c0a447f4a5475924ad4f8327"><bold id="strong-f5fcf4a57b544f91a53f2435f70db3e2"/><bold id="strong-e3cd083a28314395b1a89ea3b6ef8e36"/>1,2,3-triazole phthalimide derivatives</title>
          </caption>
          <graphic id="graphic-aab1640b778141d89e3ea22842969ad9" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage53.png"/>
        </fig>
      </sec>
      <sec>
        <title id="title-cef8c61d7e6b4499b654a14118913d5e">Anti-tuburculosis activity</title>
        <p id="paragraph-a2c5ea7b659148dda70bc553124acb6d">Stefely JA et al.,<xref id="xref-6027cc79c76f483a987bf90d153a638a" rid="R218357329794847" ref-type="bibr">56</xref> N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamides were synthesized, which served as growth inhibitors for cancer cells. Studies of the structure-activity relationship (SAR) revealed that a meta-phenoxy substitution of the N-1-benzyl group is required for antiproliferative action, while a variety of heterocyclic substitutions for the aryl group of the arylamide are tolerated. For instance, compound 13e's IC50 value for the human breast cancer cell line MCF-7 was 46 nM. In silico compare analysis revealed a connection between antiproliferative activity against the NCI-60 human tumor cell line panel and clinically relevant anti-microtubule medications like vincristine and paclitaxel.</p>
        <fig id="figure-f36155cb60f64f8ebdeed64e08499cd3" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 23 </label>
          <caption id="caption-e163ef2dfd034dce8b0443cb1c0e471b">
            <title id="title-0ce9c4a4940f4017abe8ba6119ba5bec"><bold id="strong-ed428f4be7c74cc39ae930cb062261d9"/>1,2,3-triazol-arylamides</title>
          </caption>
          <graphic id="graphic-a2840f27c43f49cc9ae642cb9590ac1e" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage54.png"/>
        </fig>
        <p id="paragraph-811feb107e9d4cf0ba3cdb1dde2dd366"> Pulipati L<bold id="strong-e3beafe1dc10493bbd736ef1a6b7d875"> </bold>et<bold id="strong-a62a6d09e93e4bb89c72c8300a75e4fb"> </bold>al., <xref id="xref-282febd2765b48b09e4c62e40bd94208" rid="R218357329794899" ref-type="bibr">57</xref> The noval compounds have been tested for antimycobacterial activity after being synthesized as dibenzo [b, d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine, and thiomorpholine. The necessary azide building block 6a-e was delivered from business dibenzo[b,d]thiophene in great yields through a five phase compound cycle. NMR and mass spectral methods were used to characterize each of the new analogues 8a-f, 9a-f, 10a-f, 11a-f, and 12a-f. Every one of the thirty new mixtures were considered in contrast to Mycobacterium tuberculosis H37Rv, and 8a, 8f, and 11e were viewed as strong analogs with MICs of 0.78 g/mL, 0.78 g/mL, and 1.56 g/mL, separately. Additionally, the cytotoxicity of these substances was lessened. The data provided some indication of Mycobacterium tuberculosis, and it is interesting to note that all six piperazine-applied dibenzo[b, d]thiophene-1,2,3-triazoles 11a-f suppressed Mtb with MICs ranging from 1.56 to 12.5 g/mL.</p>
        <p id="paragraph-46f228c71a46427198e8871c8a4185f3"> Zhang S et al.,<xref id="xref-a09c31d98c634bbe8c39d96dd24e45e2" rid="R218357329794888" ref-type="bibr">58</xref> 1,2,3, and 1,2,4-triazoles were synthesized. Triazole derivatives are recognized as a novel class of potent anti-TB options because of their potential effectiveness. Consequently, compounds containing a triazole moiety may be able to prevent the development of drug resistance to some extent and exhibit positive anti-TB activity both <italic id="e-764895d0a038">in vitro</italic> and <italic id="e-5e1e80122e5b">in vivo</italic>. The structure-activity relationship of these derivatives is also discussed, as are the advancements made in the use of triazole-containing hybrids as anti-TB medications.</p>
        <p id="p-1169be70a68a"/>
        <fig id="f-dc7b87fdf3d1" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 24 </label>
          <caption id="c-b00a160fa480">
            <title id="t-496ccbf475e3"><bold id="s-74970f9d4ff9"/>1,2,3, and 1,2,4-triazoles</title>
          </caption>
          <graphic id="g-9424bd550656" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7c0812e4-bfff-4ef4-a70a-4cf926628ac4/image/1f4acd42-af9f-45b5-8b62-4c5635e77851-uimage.png"/>
        </fig>
        <p id="p-c0f954922882"/>
        <p id="paragraph-8ea066b4d8744c749e185b7c63d2b8cd">Ali AA et al.,<xref id="xref-b2c8940a1bcb4b778663a26f007cd108" rid="R218357329794881" ref-type="bibr">59</xref> A collection of seventeen brand-new 1,2,3-triazole derivatives was successfully synthesized with high yields, and their anti-tubercular activity against <italic id="e-c0159aa3ff38">Mycobacterium</italic> TB H37Ra (ATCC 25177 strain) was evaluated in vitro. With MIC values against MBMDMQs ranging from 3.12 to 0.78 g/mL and no discernible cytotoxicity, six of the series' compounds had significant action. The molecular docking of the DprE1 (Decaprenylphosphoryl-D-ribose-2′-epimerase) enzyme's active site with the target molecules sheds light on the probable binding interactions.</p>
      </sec>
      <sec>
        <title id="title-3d6dfb002e2745d0b92b3eba4fc4cc25">Anti-cancer activity</title>
        <p id="paragraph-c12f5f42a9b04c64a30d0203b491a2bd">Yan SJ et al., <xref id="xref-353182df7dea45818eb095fee2a1c3d2" rid="R218357329794870" ref-type="bibr">60</xref> He made numerous heterocycle-melded 1,2,3-triazoles in a one-pot process at room temperature without the need of an impetus, which were then inspected <italic id="e-165a976d0e40">in vitro</italic> against an assortment of human cancer cell lines. Compared to 1,3-diazoheterocycle fused 1,2,3-triazoles, the cancer cell lines Skov-3, HL-60, A431, A549, and HepG-2 were more responsive to 1,3-oxyazoheterocycle fused 1,2,3-triazoles. Against the human tumor cell lines A431 and K562, the 4-methoxyphenyl substituted 1,3-oxazoheterocycle fused 1,2,3-triazole 6j was found to be the most effective derivative, with IC(50) values of less than 1.9 microg/mL.</p>
        <p id="paragraph-944746baa9c548e4bdf89376a61bd05a">Nagesh HN et al.,<xref id="xref-f136c927139b4622ae60da75b5d939fd" rid="R218357329794868" ref-type="bibr">61</xref> The MTT assay was used to evaluate a number of novel 6-(4-((substituted-1H-1,2,3-triazol-4-yl)piperazin-1-yl) phenanthridine analogues as antiproliferative agents against four cancer cell lines. The synthesised substances 7g and 7h were effective against all types of test cells. 7g (IC50 = 9.73 4.09 M) was effective against the THP1 cancer cell line, while 7h (IC50 = 7.22 0.32 M) was more effective than the reference medication etoposide against the HL60 cancer cell line.</p>
        <fig id="figure-545627fcfe5f448d868e405150bc507b" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 25 </label>
          <caption id="caption-9d6f19be0c74456ea05ac73301382361">
            <title id="title-89f3ecbe5ef441289786452bf2c4598a"><bold id="strong-6155b1d009bb4ea7a087ee47cfde9a25"/>Piperazin Derivatives</title>
          </caption>
          <graphic id="graphic-86097c85dc0048388f7026329e65d5cb" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage59.png"/>
        </fig>
        <p id="paragraph-81b9c05af00a446dbb1edc301ec8fbde">Farooq S et al., <xref id="xref-d10ad8ce5f124b0db74ba3042713e980" rid="R218357329794853" ref-type="bibr">62</xref> New triazoles linked to 7-hydroxycoumarins were synthesized.With IC50 upsides of 5.1, 22.7, 14.3, and 10.2 M against the bosom (MCF-7), lung (NCI-H322), prostate (PC-3) and skin (A-431) disease cell lines, separately, compound 5 outflanked any remaining tried analogs. It was eight times more sensitive than the parent substance, 7-hydroxycoumarin, against MCF-7. Compound 5 also induced apoptosis and G1 phase arrest in breast cancer cells, which had cytotoxic and cytostatic effects, respectively (MCF-7). At 8 M, the apoptotic cell population increased to 18.8% from 9.8% in the case of negative control, while G1 phase arrest increased to 54.4% from 48.1% in the negative control. In addition, Compound 5 showed a remarkable decrease in mitochondria.</p>
        <fig id="figure-3047f99e289d47b3a5fdd302a5316b03" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 26 </label>
          <caption id="caption-f5aaf1f4731348e080dca04f4aaf14fb">
            <title id="title-97ab360d17d044e4b216324c15286306">Novel Triazoles Linked 7-hydroxycoumarin Derivatives  </title>
          </caption>
          <graphic id="graphic-6b362ff09d744f6c9f4b379c830dfeab" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage60.png"/>
        </fig>
        <p id="paragraph-c83b2ac6a4e846aa962683e94bad8e1d">Venkata SR et al.,<xref id="xref-e8151ef267df47628d6c62e63af67f69" rid="R218357329794891" ref-type="bibr">63</xref> Utilizing a CuAAC (Copper catalysed azide-alkyne cycloaddition) method, a novel 8-bromo-1H-1,2,3-triazol-4-yl-2-methylquinoline derivative series and its Suzuki coupling products were created, establishing a new class of anticancer medications. The synthesised compounds' <italic id="e-c004d7ca6ba8">invitr</italic>o anticancer properties (B16F10) were evaluated in human breast cancer (MDA-MB-231) and melanoma cell lines. The new chemicals' cellular toxicity was also evaluated using common human embryonic kidney (HEK) cell lines. The substances 5c (Azetidine), 5e (Nitro benzoate), 5f (fluorobenzyl)-1H-pyrazole), 5g (Boc piperidine), 6a (cyclo propyl), 6c (5-fluoro-6-methoxypyridin-3-yl), and 6d (2-methoxypyridin-3).</p>
        <fig id="figure-e77f1173a88e4bacade90bae768563b4" orientation="portrait" fig-type="graphic" position="anchor">
          <label>Figure 27 </label>
          <caption id="caption-1fa3093f1a974ea5bd2bff15ef858f2d">
            <title id="title-7a97a775be324dc29877bb77dc33a9a3"><bold id="strong-6e7812ae03074ae0a5cb22d339f15fb8"/>Quinoline Consists of 1H‐1, 2, 3‐Triazole Hybrids</title>
          </caption>
          <graphic id="graphic-e45ca649bbdf4dcfa6de6f7b6cf5f3fb" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c66b08c8-5526-4e0e-87a5-6297e873746dimage61.png"/>
        </fig>
      </sec>
      <sec>
        <title id="t-9a2a6cbc821d">Agricultural Applications </title>
      </sec>
    </sec>
    <sec>
      <title id="title-ad314a45000f4fb5ab0656e2f6aa2774">Result and Discussion</title>
      <p id="paragraph-42549f6ef5264b49b34940c8903c22f9">As validated through the body of work reviewed in this paper, 1,2,3 triazole and piperazine  in heterocyclic compounds have amazing biological activities. This review shall give researchers access and detailed understanding on various application of 1,2,3 triazole and piperazine a novel heterocyclic subsidiary into diverse areas for new process or application. This review provides an overview to 1,2,3 triazole  subordinates of heterocyclic compounds and highlights their different biological properties. </p>
    </sec>
    <sec>
      <title id="title-9464b0e4f32e4f709b0e7d9aa056c29b">Acknowledgement</title>
      <p id="paragraph-e781cb4fcf694cf7849891739161ae65">The authors are thankful to the management, Director, Principal, and faculties of RR College of Pharmacy, Chikkabanavaram for rendering the necessary support in this work.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R218357329794903">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hossain</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nanda</surname>
              <given-names>A K</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>A Review on Heterocyclic: Synthesis and Their Application in Medicinal Chemistry of Imidazole Moiety</article-title>
          <source>Science Journal of Chemistry</source>
          <year>2018</year>
          <volume>6</volume>
          <issue>5</issue>
          <fpage>83</fpage>
          <lpage>83</lpage>
          <issn>2330-0981</issn>
          <publisher-name>Science Publishing Group</publisher-name>
          <uri>https://doi.org/10.11648/j.sjc.20180605.12</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794854">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bazgir</surname>
              <given-names>M M</given-names>
            </name>
            <name>
              <surname>Khanaposhtani</surname>
              <given-names>A A</given-names>
            </name>
            <name>
              <surname>Sooski</surname>
              <given-names/>
            </name>
            <collab/>
          </person-group>
          <year>2008</year>
          <volume>18</volume>
          <fpage>5800</fpage>
          <lpage>5803</lpage>
        </element-citation>
      </ref>
      <ref id="R218357329794864">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shinde</surname>
              <given-names>D B</given-names>
            </name>
            <name>
              <surname>Aaglawe</surname>
              <given-names>M J</given-names>
            </name>
            <name>
              <surname>Dhule</surname>
              <given-names>S S</given-names>
            </name>
            <name>
              <surname>Bahekar</surname>
              <given-names>S S</given-names>
            </name>
            <name>
              <surname>Wakte</surname>
              <given-names>P S</given-names>
            </name>
            <collab/>
          </person-group>
          <source>J. Kor. Chem. Sty</source>
          <year>2003</year>
          <volume>47</volume>
          <fpage>133</fpage>
          <lpage>136</lpage>
        </element-citation>
      </ref>
      <ref id="R218357329794905">
        <element-citation publication-type="misc">
          <person-group person-group-type="author">
            <name>
              <surname>Kozikowski</surname>
              <given-names/>
            </name>
            <collab/>
          </person-group>
          <year>1984</year>
          <volume>1</volume>
          <fpage>413</fpage>
          <lpage>413</lpage>
          <publisher-name>Pergamon Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="R218357329794882">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lipshutz</surname>
              <given-names>B H</given-names>
            </name>
            <collab/>
          </person-group>
          <source>Chem Rev</source>
          <year>1986</year>
          <volume>86</volume>
          <fpage>795</fpage>
          <lpage>795</lpage>
        </element-citation>
      </ref>
      <ref id="R218357329794850">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shipman</surname>
              <given-names>M</given-names>
            </name>
            <collab/>
          </person-group>
          <source>Contemp. Org.Synth</source>
          <year>1995</year>
        </element-citation>
      </ref>
      <ref id="R218357329794867">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thore</surname>
              <given-names>S N</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>Sunil V</given-names>
            </name>
            <name>
              <surname>Baheti</surname>
              <given-names>Kamalkishor G</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and pharmacological evaluation of 5-methyl-2-phenylthiazole-4-substituted heteroazoles as a potential anti-inflammatory and analgesic agents</article-title>
          <source>Journal of Saudi Chemical Society</source>
          <year>2016</year>
          <volume>20</volume>
          <fpage>S46</fpage>
          <lpage>S52</lpage>
          <issn>1319-6103</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.jscs.2012.09.002</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794908">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaharia</surname>
              <given-names>Valentin</given-names>
            </name>
            <name>
              <surname>Ignat</surname>
              <given-names>Adriana</given-names>
            </name>
            <name>
              <surname>Palibroda</surname>
              <given-names>Nicolae</given-names>
            </name>
            <name>
              <surname>Ngameni</surname>
              <given-names>Bathélémy</given-names>
            </name>
            <name>
              <surname>Kuete</surname>
              <given-names>Victor</given-names>
            </name>
            <name>
              <surname>Fokunang</surname>
              <given-names>Charles N</given-names>
            </name>
            <name>
              <surname>Moungang</surname>
              <given-names>Marlyse L</given-names>
            </name>
            <name>
              <surname>Ngadjui</surname>
              <given-names>Bonaventure T</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis of some p-toluenesulfonyl-hydrazinothiazoles and hydrazino-bis-thiazoles and their anticancer activity</article-title>
          <source>European Journal of Medicinal Chemistry</source>
          <year>2010</year>
          <volume>45</volume>
          <issue>11</issue>
          <fpage>5080</fpage>
          <lpage>5085</lpage>
          <issn>0223-5234</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.ejmech.2010.08.017</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794869">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karegoudar</surname>
              <given-names>Prakash</given-names>
            </name>
            <name>
              <surname>Karthikeyan</surname>
              <given-names>Mari Sithambaram</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>Dasappa Jagadeesh</given-names>
            </name>
            <name>
              <surname>Mahalinga</surname>
              <given-names>Manjathuru</given-names>
            </name>
            <name>
              <surname>Holla</surname>
              <given-names>Bantwal Shivarama</given-names>
            </name>
            <name>
              <surname>Kumari</surname>
              <given-names>Nalilu Sucheta</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis of some novel 2,4-disubstituted thiazoles as possible antimicrobial agents</article-title>
          <source>European Journal of Medicinal Chemistry</source>
          <year>2008</year>
          <volume>43</volume>
          <issue>2</issue>
          <fpage>261</fpage>
          <lpage>267</lpage>
          <issn>0223-5234</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https;//doi.org/10.1016/j.ejmech.2007.03.014</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794897">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayhoub</surname>
              <given-names>Abdelrahman S</given-names>
            </name>
            <name>
              <surname>Khaliq</surname>
              <given-names>Mansoora</given-names>
            </name>
            <name>
              <surname>Botting</surname>
              <given-names>Carolyn</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Ze</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>Richard J</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>Mark</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>An investigation of phenylthiazole antiflaviviral agents</article-title>
          <source>Bioorganic &amp; Medicinal Chemistry</source>
          <year>2011</year>
          <volume>19</volume>
          <issue>12</issue>
          <fpage>3845</fpage>
          <lpage>3854</lpage>
          <issn>0968-0896</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.bmc.2011.04.041</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794879">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goncales</surname>
              <given-names>C E P</given-names>
            </name>
            <name>
              <surname>Araldi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Panatieri</surname>
              <given-names>R B</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>J B T</given-names>
            </name>
            <name>
              <surname>Zeni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nogueira</surname>
              <given-names>C W</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Antinociceptive properties of acetylenic thiophene and furan derivatives: Evidence for the mechanism of action</article-title>
          <source>Life Sciences</source>
          <year>2005</year>
          <volume>76</volume>
          <issue>19</issue>
          <fpage>2221</fpage>
          <lpage>2234</lpage>
          <issn>0024-3205</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.lfs.2004.10.038</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794875">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawood</surname>
              <given-names>Kamal M</given-names>
            </name>
            <name>
              <surname>Abdel-Gawad</surname>
              <given-names>Hassan</given-names>
            </name>
            <name>
              <surname>Rageb</surname>
              <given-names>Eman A</given-names>
            </name>
            <name>
              <surname>Ellithey</surname>
              <given-names>Mohey</given-names>
            </name>
            <name>
              <surname>Mohamed</surname>
              <given-names>Hanan A</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles</article-title>
          <source>Bioorganic &amp; Medicinal Chemistry</source>
          <year>2006</year>
          <volume>14</volume>
          <issue>11</issue>
          <fpage>3672</fpage>
          <lpage>3680</lpage>
          <issn>0968-0896</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.bmc.2006.01.033</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794866">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mabkhot</surname>
              <given-names>Yahia N</given-names>
            </name>
            <name>
              <surname>Kaal</surname>
              <given-names>Nahed A</given-names>
            </name>
            <name>
              <surname>Alterary</surname>
              <given-names>Seham</given-names>
            </name>
            <name>
              <surname>Al-Showiman</surname>
              <given-names>Salim S</given-names>
            </name>
            <name>
              <surname>Barakat</surname>
              <given-names>Assem</given-names>
            </name>
            <name>
              <surname>Ghabbour</surname>
              <given-names>Hazem A</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>Wolfgang</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis, In-Vitro Antibacterial, Antifungal, and Molecular Modeling of Potent Anti-Microbial Agents with a Combined Pyrazole and Thiophene Pharmacophore</article-title>
          <source>Molecules</source>
          <year>2015</year>
          <volume>20</volume>
          <issue>5</issue>
          <fpage>8712</fpage>
          <lpage>8729</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3390/molecules20058712</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794878">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malah</surname>
              <given-names>Tamer El</given-names>
            </name>
            <name>
              <surname>Nour</surname>
              <given-names>Hany F</given-names>
            </name>
            <name>
              <surname>Satti</surname>
              <given-names>Amira A E</given-names>
            </name>
            <name>
              <surname>Hemdan</surname>
              <given-names>Bahaa A</given-names>
            </name>
            <name>
              <surname>El-Sayed</surname>
              <given-names>Wael A</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Design, Synthesis, and Antimicrobial Activities of 1,2,3-Triazole Glycoside Clickamers</article-title>
          <source>Molecules</source>
          <year>2020</year>
          <volume>25</volume>
          <issue>4</issue>
          <fpage>790</fpage>
          <lpage>790</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/ 10.3390/molecules25040790</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794860">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gondru</surname>
              <given-names>Ramesh</given-names>
            </name>
            <name>
              <surname>Kanugala</surname>
              <given-names>Sirisha</given-names>
            </name>
            <name>
              <surname>Raj</surname>
              <given-names>Sneha</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>C Ganesh</given-names>
            </name>
            <name>
              <surname>Pasupuleti</surname>
              <given-names>Mukesh</given-names>
            </name>
            <name>
              <surname>Banothu</surname>
              <given-names>Janardhan</given-names>
            </name>
            <name>
              <surname>Bavantula</surname>
              <given-names>Rajitha</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>1,2,3-triazole-thiazole hybrids: Synthesis, in vitro antimicrobial activity and antibiofilm studies</article-title>
          <source>Bioorganic &amp; Medicinal Chemistry Letters</source>
          <year>2021</year>
          <volume>33</volume>
          <fpage>127746</fpage>
          <lpage>127746</lpage>
          <issn>0960-894X</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.bmcl.2020.127746</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794880">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaproń</surname>
              <given-names>Barbara</given-names>
            </name>
            <name>
              <surname>Czarnomysy</surname>
              <given-names>Robert</given-names>
            </name>
            <name>
              <surname>Wysokiński</surname>
              <given-names>Mariusz</given-names>
            </name>
            <name>
              <surname>Andrys</surname>
              <given-names>Rudolf</given-names>
            </name>
            <name>
              <surname>Musilek</surname>
              <given-names>Kamil</given-names>
            </name>
            <name>
              <surname>Angeli</surname>
              <given-names>Andrea</given-names>
            </name>
            <name>
              <surname>Supuran</surname>
              <given-names>Claudiu T</given-names>
            </name>
            <name>
              <surname>Plech</surname>
              <given-names>Tomasz</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy</article-title>
          <source>Journal of Enzyme Inhibition and Medicinal Chemistry</source>
          <year>2020</year>
          <volume>35</volume>
          <issue>1</issue>
          <fpage>993</fpage>
          <lpage>1002</lpage>
          <issn>1475-6366</issn>
          <publisher-name>Informa UK Limited</publisher-name>
          <uri>https://doi.org/10.1080/14756366.2020.1748026</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794859">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azim</surname>
              <given-names>Tabinda</given-names>
            </name>
            <name>
              <surname>Wasim</surname>
              <given-names>Muhammad</given-names>
            </name>
            <name>
              <surname>Akhtar</surname>
              <given-names>Muhammad Shoaib</given-names>
            </name>
            <name>
              <surname>Akram</surname>
              <given-names>Irfan</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>An in vivo evaluation of anti-inflammatory, analgesic and anti-pyretic activities of newly synthesized 1, 2, 4 Triazole derivatives</article-title>
          <source>BMC Complementary Medicine and Therapies</source>
          <year>2021</year>
          <volume>21</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>5</lpage>
          <publisher-name>Springer Science and Business Media LLC</publisher-name>
          <uri>https://doi.org/10.1186/s12906-021-03485-x</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794890">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dai</surname>
              <given-names>Zhi-Cheng C</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Yong-Fei F</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Mao</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Sheng-Kun K</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Ting-Ting T</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Li</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Jian-Xin X</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>Shao-Song S</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Hai-Liang L</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>Yong-Hao H</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and antifungal activity of 1,2,3-triazole phenylhydrazone derivatives</article-title>
          <source>Organic &amp; Biomolecular Chemistry</source>
          <year>2015</year>
          <volume>13</volume>
          <issue>2</issue>
          <fpage>477</fpage>
          <lpage>486</lpage>
          <issn>1477-0520</issn>
          <publisher-name>Royal Society of Chemistry (RSC)</publisher-name>
          <uri>https://doi.org/10.1039/C4OB01758G</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794906">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paprocka</surname>
              <given-names>Renata</given-names>
            </name>
            <name>
              <surname>Kołodziej</surname>
              <given-names>Przemysław</given-names>
            </name>
            <name>
              <surname>Wiese-Szadkowska</surname>
              <given-names>Małgorzata</given-names>
            </name>
            <name>
              <surname>Helmin-Basa</surname>
              <given-names>Anna</given-names>
            </name>
            <name>
              <surname>Bogucka-Kocka</surname>
              <given-names>Anna</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Evaluation of Anthelmintic and Anti-Inflammatory Activity of 1,2,4-Triazole Derivatives</article-title>
          <source>Molecules</source>
          <year>2022</year>
          <volume>27</volume>
          <issue>14</issue>
          <fpage>4488</fpage>
          <lpage>4488</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3390/molecules27144488</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794894">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>Jeetendra Kumar</given-names>
            </name>
            <name>
              <surname>Mishra</surname>
              <given-names>Pradeep</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Antimicrobial and anthelmintic activities of some newly synthesized triazoles</article-title>
          <source>Asian Journal of Pharmaceutical and Clinical Research</source>
          <year>2017</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>139</fpage>
          <lpage>139</lpage>
          <issn>0974-2441</issn>
          <publisher-name>Innovare Academic Sciences Pvt Ltd</publisher-name>
          <uri>https://doi.org/10.22159/ajpcr.2017.v10i6.17800</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794849">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silalai</surname>
              <given-names>Patamawadee</given-names>
            </name>
            <name>
              <surname>Jaipea</surname>
              <given-names>Suwichada</given-names>
            </name>
            <name>
              <surname>Tocharus</surname>
              <given-names>Jiraporn</given-names>
            </name>
            <name>
              <surname>Athipornchai</surname>
              <given-names>Anan</given-names>
            </name>
            <name>
              <surname>Suksamrarn</surname>
              <given-names>Apichart</given-names>
            </name>
            <name>
              <surname>Saeeng</surname>
              <given-names>Rungnapha</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>New 1,2,3-Triazole-genipin Analogues and Their Anti-Alzheimer’s Activity</article-title>
          <source>ACS Omega</source>
          <year>2022</year>
          <volume>7</volume>
          <issue>28</issue>
          <fpage>24302</fpage>
          <lpage>24316</lpage>
          <issn>2470-1343</issn>
          <publisher-name>American Chemical Society (ACS)</publisher-name>
          <uri>https://doi.org/10.1021/acsomega.2c01593</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794887">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oramas-Royo</surname>
              <given-names/>
            </name>
            <name>
              <surname>López-Rojas</surname>
              <given-names/>
            </name>
            <name>
              <surname>Amesty</surname>
              <given-names/>
            </name>
            <name>
              <surname>Gutiérrez</surname>
              <given-names/>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names/>
            </name>
            <name>
              <surname>Martín-Rodríguez</surname>
              <given-names/>
            </name>
            <name>
              <surname>Fernández-Pérez</surname>
              <given-names/>
            </name>
            <name>
              <surname>Estévez-Braun</surname>
              <given-names/>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Antiplasmodial Activity of 1,2,3-Triazole-Naphthoquinone Conjugates</article-title>
          <source>Molecules</source>
          <year>2019</year>
          <volume>24</volume>
          <issue>21</issue>
          <fpage>3917</fpage>
          <lpage>3917</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3390/molecules24213917</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794873">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaikh</surname>
              <given-names>Mubarak H</given-names>
            </name>
            <name>
              <surname>Subhedar</surname>
              <given-names>Dnyaneshwar D</given-names>
            </name>
            <name>
              <surname>Nawale</surname>
              <given-names>Laxman</given-names>
            </name>
            <name>
              <surname>Sarkar</surname>
              <given-names>Dhiman</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>Firoz A Kalam</given-names>
            </name>
            <name>
              <surname>Sangshetti</surname>
              <given-names>Jaiprakash N</given-names>
            </name>
            <name>
              <surname>Shingate</surname>
              <given-names>Bapurao B</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study</article-title>
          <source>Med Chem Comm</source>
          <year>2015</year>
          <volume>6</volume>
          <issue>6</issue>
          <fpage>1104</fpage>
          <lpage>1116</lpage>
          <issn>2040-2503</issn>
          <publisher-name>Royal Society of Chemistry (RSC)</publisher-name>
          <uri>https://doi.org/10.1039/C5MD00057B</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794896">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gogoi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Baishya</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Saikia</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Barua</surname>
              <given-names>N C</given-names>
            </name>
            <name>
              <surname>Dohutia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>A K</given-names>
            </name>
            <name>
              <surname>Prakash</surname>
              <given-names>A</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Antimalarial activity of a novel series of artemisinin-derived 1, 2, 3-triazole dimers</article-title>
          <source>Asian Pacific Journal of Tropical Medicine</source>
          <year>2019</year>
          <volume>12</volume>
          <issue>5</issue>
          <fpage>195</fpage>
          <lpage>195</lpage>
          <uri>https://doi.org/10.4103/1995-7645.259240</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794901">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>Lian‐shun S</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>Man‐jie J</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Feng</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Duan</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>1,2,3‐Triazole hybrids with anti‐HIV‐1 activity</article-title>
          <source>Archiv der Pharmazie</source>
          <year>2021</year>
          <volume>354</volume>
          <issue>1</issue>
          <issn>0365-6233</issn>
          <publisher-name>Wiley</publisher-name>
          <uri>https://doi.org/10.1002/ardp.202000163</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794861">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourakadi</surname>
              <given-names>Khadija El</given-names>
            </name>
            <name>
              <surname>Mekhzoum</surname>
              <given-names>Mohamed El Mehdi</given-names>
            </name>
            <name>
              <surname>Saby</surname>
              <given-names>Charles</given-names>
            </name>
            <name>
              <surname>Morjani</surname>
              <given-names>Hamid</given-names>
            </name>
            <name>
              <surname>Chakchak</surname>
              <given-names>Hind</given-names>
            </name>
            <name>
              <surname>Merghoub</surname>
              <given-names>Nawal</given-names>
            </name>
            <name>
              <surname>Qaiss</surname>
              <given-names>Abou El Kacem</given-names>
            </name>
            <name>
              <surname>Bouhfid</surname>
              <given-names>Rachid</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis, characterization and in vitro anticancer activity of thiabendazole-derived 1,2,3-triazole derivatives</article-title>
          <source>New Journal of Chemistry</source>
          <year>2020</year>
          <volume>44</volume>
          <issue>28</issue>
          <fpage>12099</fpage>
          <lpage>12106</lpage>
          <issn>1144-0546</issn>
          <publisher-name>Royal Society of Chemistry (RSC)</publisher-name>
          <uri>https://doi.org/10.1039/C9NJ05685H</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794904">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le</surname>
              <given-names>Thanh Thanh</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>Phung Thi Kim</given-names>
            </name>
            <name>
              <surname>Dam</surname>
              <given-names>Hai Thi Thanh</given-names>
            </name>
            <name>
              <surname>Vo</surname>
              <given-names>Duy Duc</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>Thanh Tin</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Anticancer Activity of New 1,2,3-Triazole-Amino Acid Conjugates</article-title>
          <source>Molbank</source>
          <year>2021</year>
          <volume>2021</volume>
          <issue>2</issue>
          <fpage>1204</fpage>
          <lpage>1204</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3390/M1204</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794858">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>Ting</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Xiangyang</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Wenhong</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>Guihua</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Feng</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>1,2,3-Triazole-Containing Compounds as Anti–Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure–Activity Relationship</article-title>
          <source>Frontiers in Pharmacology</source>
          <year>2021</year>
          <volume>12</volume>
          <fpage>1374</fpage>
          <lpage>1374</lpage>
          <publisher-name>Frontiers Media SA</publisher-name>
          <uri>https://doi.org/10.3389/fphar.2021.661173</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794883">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lakkakula</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mukkanti</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sridhar</surname>
              <given-names>G</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Anticancer Activity of 1,2,3-Triazole Fused N-Arylpyrazole Derivatives</article-title>
          <source>Russian Journal of General Chemistry</source>
          <year>2019</year>
          <volume>89</volume>
          <issue>4</issue>
          <fpage>831</fpage>
          <lpage>835</lpage>
          <issn>1070-3632</issn>
          <publisher-name>Pleiades Publishing Ltd</publisher-name>
          <uri>https://doi.org/10.1134/S1070363219040315</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794884">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pokhodylo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shyyka</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Matiychuk</surname>
              <given-names>V</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity</article-title>
          <source>Scientia Pharmaceutica</source>
          <year>2013</year>
          <volume>81</volume>
          <issue>3</issue>
          <fpage>663</fpage>
          <lpage>676</lpage>
          <issn>0036-8709</issn>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3797/scipharm.1302-04</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794892">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lima-Neto</surname>
              <given-names>Reginaldo G</given-names>
            </name>
            <name>
              <surname>Cavalcante</surname>
              <given-names>Nery N M</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>Rajendra M</given-names>
            </name>
            <name>
              <surname>Junior</surname>
              <given-names>Francisco J B Mendonça</given-names>
            </name>
            <name>
              <surname>Wanderley</surname>
              <given-names>Almir G</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>Rejane P</given-names>
            </name>
            <name>
              <surname>Anjos</surname>
              <given-names>Janaína V Dos</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis of 1,2,3-Triazole Derivatives and in Vitro Antifungal Evaluation on Candida Strains</article-title>
          <source>Molecules</source>
          <year>2012</year>
          <volume>17</volume>
          <issue>5</issue>
          <fpage>5882</fpage>
          <lpage>5892</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3390/molecules17055882</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794862">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Tao</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>Zhiyong</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>Xiaowu</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Linjie</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Ling</given-names>
            </name>
            <name>
              <surname>Cen</surname>
              <given-names>Shan</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Naiming</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Yongzhou</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists</article-title>
          <source>PLoS ONE</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>1</issue>
          <fpage>53636</fpage>
          <lpage>53636</lpage>
          <publisher-name>Public Library of Science (PLoS)</publisher-name>
          <uri>https://doi.org/10.1371/journal.pone.0053636</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794872">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Bao-Lei L</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>Yi-Zhou Z</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Li-Yuan Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Yan Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Xiao Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Zheng-Ming M</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Fungicidal Activities of Novel 1,2,4-Triazole Thione Derivatives Containing 1,2,3-Triazole and Substituted Piperazine Moieties</article-title>
          <source>Phosphorus, Sulfur, and Silicon and the Related Elements</source>
          <year>2016</year>
          <volume>191</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <issn>1042-6507</issn>
          <publisher-name>Informa UK Limited</publisher-name>
          <uri>https://doi.org/10.1080/10426507.2015.1085040</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794907">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jadhav</surname>
              <given-names>Rahul P</given-names>
            </name>
            <name>
              <surname>Raundal</surname>
              <given-names>Hemant N</given-names>
            </name>
            <name>
              <surname>Patil</surname>
              <given-names>Amar A</given-names>
            </name>
            <name>
              <surname>Bobade</surname>
              <given-names>Vivek D</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and biological evaluation of a series of 1,4-disubstituted 1,2,3-triazole derivatives as possible antimicrobial agents</article-title>
          <source>Journal of Saudi Chemical Society</source>
          <year>2017</year>
          <volume>21</volume>
          <issue>2</issue>
          <fpage>152</fpage>
          <lpage>159</lpage>
          <issn>1319-6103</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.jscs.2015.03.003</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794886">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Yanwei</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Kehan</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>Guojing</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Lei</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Qiuye</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Weihua</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Shichong</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Antifungal Activity of Novel Triazole Compounds Containing Piperazine Moiety</article-title>
          <source>Molecules</source>
          <year>2014</year>
          <volume>19</volume>
          <issue>8</issue>
          <fpage>11333</fpage>
          <lpage>11340</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3390/molecules190811333</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794848">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Danne</surname>
              <given-names>Ashruba B</given-names>
            </name>
            <name>
              <surname>Deshpande</surname>
              <given-names>Mukund V</given-names>
            </name>
            <name>
              <surname>Sangshetti</surname>
              <given-names>Jaiprakash N</given-names>
            </name>
            <name>
              <surname>Khedkar</surname>
              <given-names>Vijay M</given-names>
            </name>
            <name>
              <surname>Shingate</surname>
              <given-names>Bapurao B</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>New 1,2,3-Triazole-Appended Bis-pyrazoles: Synthesis, Bioevaluation, and Molecular Docking</article-title>
          <source>ACS Omega</source>
          <year>2021</year>
          <volume>6</volume>
          <issue>38</issue>
          <fpage>24879</fpage>
          <lpage>24890</lpage>
          <issn>2470-1343</issn>
          <publisher-name>American Chemical Society (ACS)</publisher-name>
          <uri>https://doi.org/10.1021/acsomega.1c03734</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794902">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Qiu Mei</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Zhen</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>Guang Xun</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Yi M</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Xiang Hua</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>1,2,3-triazole-dithiocarbamate-naphthalimides: Synthesis, characterization, and biological evaluation</article-title>
          <source>Journal of Chemical Research</source>
          <year>2021</year>
          <volume>45</volume>
          <issue>3-4</issue>
          <fpage>258</fpage>
          <lpage>264</lpage>
          <issn>1747-5198</issn>
          <publisher-name>SAGE Publications</publisher-name>
          <uri>https://doi.org/10.1177/1747519820966971</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794909">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sriram</surname>
              <given-names>Dharmarajan</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>Debjani</given-names>
            </name>
            <name>
              <surname>Yogeeswari</surname>
              <given-names>Perumal</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Efavirenz Mannich bases: Synthesis, anti-HIV and antitubercular activities</article-title>
          <source>Journal of Enzyme Inhibition and Medicinal Chemistry</source>
          <year>2009</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>5</lpage>
          <issn>1475-6366</issn>
          <publisher-name>Informa UK Limited</publisher-name>
          <uri>https://doi.org/10.1080/14756360902784425</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794857">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogdanov</surname>
              <given-names>Andrei V</given-names>
            </name>
            <name>
              <surname>Vazykhova</surname>
              <given-names>Al’bina M</given-names>
            </name>
            <name>
              <surname>Khasiyatullina</surname>
              <given-names>Nadezhda R</given-names>
            </name>
            <name>
              <surname>Krivolapov</surname>
              <given-names>Dmitry B</given-names>
            </name>
            <name>
              <surname>Dobrynin</surname>
              <given-names>Alexey B</given-names>
            </name>
            <name>
              <surname>Voloshina</surname>
              <given-names>Alexandra D</given-names>
            </name>
            <name>
              <surname>Mironov</surname>
              <given-names>Vladimir F</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>New N-Mannich bases obtained from isatin and piperazine derivatives: the synthesis and evaluation of antimicrobial activity</article-title>
          <source>Chemistry of Heterocyclic Compounds</source>
          <year>2016</year>
          <volume>52</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>30</lpage>
          <issn>0009-3122</issn>
          <publisher-name>Springer Science and Business Media LLC</publisher-name>
          <uri>https://doi.org/10.1007/s10593-016-1826-6</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794889">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paneth</surname>
              <given-names>Agata</given-names>
            </name>
            <name>
              <surname>Trotsko</surname>
              <given-names>Nazar</given-names>
            </name>
            <name>
              <surname>Popiołek</surname>
              <given-names>Łukasz</given-names>
            </name>
            <name>
              <surname>Grzegorczyk</surname>
              <given-names>Agnieszka</given-names>
            </name>
            <name>
              <surname>Krzanowski</surname>
              <given-names>Tomasz</given-names>
            </name>
            <name>
              <surname>Janowska</surname>
              <given-names>Sara</given-names>
            </name>
            <name>
              <surname>Malm</surname>
              <given-names>Anna</given-names>
            </name>
            <name>
              <surname>Wujec</surname>
              <given-names>Monika</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Antibacterial Evaluation of Mannich Bases Derived from 1,2,4‐Triazole</article-title>
          <source>Chemistry &amp; Biodiversity</source>
          <year>2019</year>
          <volume>16</volume>
          <issue>10</issue>
          <fpage>1900377</fpage>
          <lpage>1900377</lpage>
          <issn>1612-1872</issn>
          <publisher-name>Wiley</publisher-name>
          <uri>https://doi.org/10.1002/cbdv.201900377</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794856">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isloor</surname>
              <given-names>Arun M</given-names>
            </name>
            <name>
              <surname>Kalluraya</surname>
              <given-names>Balakrishna</given-names>
            </name>
            <name>
              <surname>Shetty</surname>
              <given-names>Prashanth</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Regioselective reaction: Synthesis, characterization and pharmacological studies of some new Mannich bases derived from 1,2,4-triazoles</article-title>
          <source>European Journal of Medicinal Chemistry</source>
          <year>2009</year>
          <volume>44</volume>
          <issue>9</issue>
          <fpage>3784</fpage>
          <lpage>3787</lpage>
          <issn>0223-5234</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.ejmech.2009.04.038</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794855">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amani</surname>
              <given-names>A M</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Biological Activity of Piperazine Derivatives of Phenothiazine</article-title>
          <source>Drug Research</source>
          <year>2015</year>
          <volume>65</volume>
          <issue>01</issue>
          <fpage>5</fpage>
          <lpage>8</lpage>
          <issn>2194-9379</issn>
          <publisher-name>Georg Thieme Verlag KG</publisher-name>
          <uri>https://doi.org/10.1055/s-0033-1364001</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794877">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tan</surname>
              <given-names>Wenqiang</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Qing</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Huali</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Yan</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Jingjing</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>Fang</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Zhanyong</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis, characterization, and antibacterial property of novel starch derivatives with 1,2,3-triazole</article-title>
          <source>Carbohydrate Polymers</source>
          <year>2016</year>
          <volume>142</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <issn>0144-8617</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.carbpol.2016.01.007</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794876">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gan</surname>
              <given-names>Lin-Ling L</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Hui-Zhen Z</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Cheng-He H</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Design, Synthesis and Relational Biological Evaluation of Novel Diphenylpiperazine 1,2,3-triazole Derivatives</article-title>
          <source>Indian Journal of Pharmaceutical Sciences</source>
          <year>2018</year>
          <volume>80</volume>
          <issue>6</issue>
          <fpage>1045</fpage>
          <lpage>1056</lpage>
          <publisher-name>OMICS Publishing Group</publisher-name>
          <uri>https://doi.org/10.4172/pharmaceutical-sciences.1000455</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794898">
        <element-citation publication-type="misc">
          <person-group person-group-type="author">
            <name>
              <surname>Thriveni</surname>
              <given-names>K S</given-names>
            </name>
            <name>
              <surname>Padmashali</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Siddesh</surname>
              <given-names>M B</given-names>
            </name>
            <name>
              <surname>Sandeep</surname>
              <given-names>C</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis of pyrimidine incorporated piperazine derivatives and their antimicrobial activity</article-title>
          <source>Indian journal of pharmaceutical sciences</source>
          <year>2014</year>
          <volume>76</volume>
          <fpage>332</fpage>
          <lpage>332</lpage>
          <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171870/</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794871">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El Malah</surname>
              <given-names>Tamer</given-names>
            </name>
            <name>
              <surname>Nour</surname>
              <given-names>Hany F</given-names>
            </name>
            <name>
              <surname>Satti</surname>
              <given-names>Amira A E</given-names>
            </name>
            <name>
              <surname>Hemdan</surname>
              <given-names>Bahaa A</given-names>
            </name>
            <name>
              <surname>El-Sayed</surname>
              <given-names>Wael A</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Design, Synthesis, and Antimicrobial Activities of 1,2,3-Triazole Glycoside Clickamers</article-title>
          <source>Molecules</source>
          <year>2020</year>
          <volume>25</volume>
          <issue>4</issue>
          <fpage>790</fpage>
          <lpage>790</lpage>
          <publisher-name>MDPI AG</publisher-name>
        </element-citation>
      </ref>
      <ref id="R218357329794851">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khanage</surname>
              <given-names>S G</given-names>
            </name>
            <name>
              <surname>Raju</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mohite</surname>
              <given-names>P B</given-names>
            </name>
            <name>
              <surname>Pandhare</surname>
              <given-names>R B</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Analgesic activity of some 1, 2, 4-triazole heterocycles clubbed with pyrazole, tetrazole, isoxazole and pyrimidine</article-title>
          <source>Advanced Pharmaceutical Bulletin</source>
          <year>2013</year>
          <volume>3</volume>
          <issue>1</issue>
          <fpage>13</fpage>
          <lpage>13</lpage>
          <uri>https://doi.org/10.5681/apb.2013.003</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794885">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lima</surname>
              <given-names>Josefa A Da Cunha</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>Jadson De Farias</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>Cosme S</given-names>
            </name>
            <name>
              <surname>Caiana</surname>
              <given-names>Rodrigo R A</given-names>
            </name>
            <name>
              <surname>Moraes</surname>
              <given-names>Marcílio M De</given-names>
            </name>
            <name>
              <surname>Câmara</surname>
              <given-names>Claudio A G Da</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>Juliano C R</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis of new 1,4-disubstituted 1,2,3-triazoles using the CuAAC reaction and determination of their antioxidant activities</article-title>
          <source>Anais da Academia Brasileira de Ciências</source>
          <year>2021</year>
          <volume>93</volume>
          <issue>3</issue>
          <issn>0001-3765</issn>
          <publisher-name>FapUNIFESP (SciELO)</publisher-name>
          <uri> https://doi.org/10.1590/0001-3765202120201672</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794900">
        <element-citation publication-type="misc">
          <person-group person-group-type="author">
            <name>
              <surname>Montes-Ávila</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sarmiento-Sánchez</surname>
              <given-names>J I</given-names>
            </name>
            <name>
              <surname>Delgado-Vargas</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rivero</surname>
              <given-names>I A</given-names>
            </name>
            <name>
              <surname>Díaz-Camacho</surname>
              <given-names>S P</given-names>
            </name>
            <name>
              <surname>Uribe-Beltrán</surname>
              <given-names>M</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Antioxidant activity and antimicrobial evaluation of 1-benzyl-1, 2, 3-triazole</article-title>
          <source> Acta universitaria</source>
          <year>2016</year>
          <volume>26</volume>
          <fpage>63</fpage>
          <lpage>70</lpage>
          <uri>https://doi.org/10.15174/au.2016.937 </uri>
        </element-citation>
      </ref>
      <ref id="R218357329794863">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deshmukh</surname>
              <given-names>Tejshri R</given-names>
            </name>
            <name>
              <surname>Khare</surname>
              <given-names>Smita P</given-names>
            </name>
            <name>
              <surname>Krishna</surname>
              <given-names>Vagolu S</given-names>
            </name>
            <name>
              <surname>Sriram</surname>
              <given-names>Dharmarajan</given-names>
            </name>
            <name>
              <surname>Sangshetti</surname>
              <given-names>Jaiprakash N</given-names>
            </name>
            <name>
              <surname>Khedkar</surname>
              <given-names>Vijay M</given-names>
            </name>
            <name>
              <surname>Shingate</surname>
              <given-names>Bapurao B</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis, bioevaluation and molecular docking study of new piperazine and amide linked dimeric 1,2,3-triazoles</article-title>
          <source>Synthetic Communications</source>
          <year>2020</year>
          <volume>50</volume>
          <issue>2</issue>
          <fpage>271</fpage>
          <lpage>288</lpage>
          <issn>0039-7911</issn>
          <publisher-name>Informa UK Limited</publisher-name>
          <uri>https://doi.org/10.1080/00397911.2019.1695275</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794874">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>Jeetendra Kumar</given-names>
            </name>
            <name>
              <surname>Mishra</surname>
              <given-names>Pradeep</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Antimicrobial and anthelmintic activities of some newly synthesized triazoles</article-title>
          <source>Asian Journal of Pharmaceutical and Clinical Research</source>
          <year>2017</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>139</fpage>
          <lpage>139</lpage>
          <issn>0974-2441</issn>
          <publisher-name>Innovare Academic Sciences Pvt Ltd</publisher-name>
          <uri>https://doi.org/10.22159/ajpcr.2017.v10i6.17800</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794852">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jayappa</surname>
              <given-names>Madhu Kumar Dogganal</given-names>
            </name>
            <name>
              <surname>Dasappa</surname>
              <given-names>Jagadeesh Prasad</given-names>
            </name>
            <name>
              <surname>Chandrashekar</surname>
              <given-names>Konambi Ramaiah</given-names>
            </name>
            <name>
              <surname>Sheik</surname>
              <given-names>Sana</given-names>
            </name>
            <name>
              <surname>Chaluvaiah</surname>
              <given-names>Kumar</given-names>
            </name>
            <name>
              <surname>Naik</surname>
              <given-names>Prashantha</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis, Antimicrobial and Anthelmintic Activity Studies of Some Novel Triazole Schiff and Mannich Bases</article-title>
          <source>Der Pharma Chemica</source>
          <year>2017</year>
          <volume>9</volume>
          <issue>12</issue>
          <fpage>163</fpage>
          <lpage>171</lpage>
          <uri>https://www.derpharmachemica.com/pharma-chemica/synthesis-antimicrobial-and-anthelmintic-activity-studies-of-some-novel-triazole-schiff-and-mannich-bases.pdf</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794865">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dastjerdi</surname>
              <given-names>Hossein Fasihi</given-names>
            </name>
            <name>
              <surname>Naderi</surname>
              <given-names>Nima</given-names>
            </name>
            <name>
              <surname>Nematpour</surname>
              <given-names>Manijeh</given-names>
            </name>
            <name>
              <surname>Rezaee</surname>
              <given-names>Elham</given-names>
            </name>
            <name>
              <surname>Mahboubi-Rabbani</surname>
              <given-names>Mohammad</given-names>
            </name>
            <name>
              <surname>Ebrahimi</surname>
              <given-names>Melika</given-names>
            </name>
            <name>
              <surname>Hosseinipoor</surname>
              <given-names>Samaneh</given-names>
            </name>
            <name>
              <surname>Hosseini</surname>
              <given-names>Omid</given-names>
            </name>
            <name>
              <surname>Tabatabai</surname>
              <given-names>Sayyed Abbas</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Design, synthesis and anti-diabetic activity of novel 1, 2, 3-triazole-5-carboximidamide derivatives as dipeptidyl peptidase-4 inhibitors</article-title>
          <source>Journal of Molecular Structure</source>
          <year>2020</year>
          <volume>1221</volume>
          <fpage>128745</fpage>
          <lpage>128745</lpage>
          <issn>0022-2860</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.molstruc.2020.128745</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794893">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaya</surname>
              <given-names>Betül</given-names>
            </name>
            <name>
              <surname>Garima</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Temel,</surname>
              <given-names>Halide Edip</given-names>
            </name>
            <name>
              <surname>Kaplancıklı</surname>
              <given-names>Zafer Asım</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and biological evaluation of novel piperazine containing hydrazone derivatives</article-title>
          <source>Journal of Chemistry</source>
          <year>2016</year>
          <uri>https://doi.org/10.1155/2016/5878410</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794895">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Assis</surname>
              <given-names>Shalom Pôrto De Oliveira</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>Moara Targino Da</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>Ronaldo Nascimento De</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>Vera Lúcia De Menezes</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Anti-Inflammatory Activity of New Alkyl-Substituted Phthalimide 1H-1,2,3-Triazole Derivatives</article-title>
          <source>The Scientific World Journal</source>
          <year>2012</year>
          <volume>2012</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <publisher-name>Hindawi Limited</publisher-name>
          <uri>https://doi.org/10.1100/2012/925925</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794847">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stefely</surname>
              <given-names>Jonathan A</given-names>
            </name>
            <name>
              <surname>Palchaudhuri</surname>
              <given-names>Rahul</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>Patricia A</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>Rebecca J</given-names>
            </name>
            <name>
              <surname>Moraski</surname>
              <given-names>Garrett C</given-names>
            </name>
            <name>
              <surname>Hergenrother</surname>
              <given-names>Paul J</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>Marvin J</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>N-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a New Scaffold that Provides Rapid Access to Antimicrotubule Agents: Synthesis and Evaluation of Antiproliferative Activity Against Select Cancer Cell Lines</article-title>
          <source>Journal of Medicinal Chemistry</source>
          <year>2010</year>
          <volume>53</volume>
          <issue>8</issue>
          <fpage>3389</fpage>
          <lpage>3395</lpage>
          <issn>0022-2623</issn>
          <publisher-name>American Chemical Society (ACS)</publisher-name>
          <uri>https://doi.org/10.1021/jm1000979</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794899">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pulipati</surname>
              <given-names>Lokesh</given-names>
            </name>
            <name>
              <surname>Yogeeswari</surname>
              <given-names>Perumal</given-names>
            </name>
            <name>
              <surname>Sriram</surname>
              <given-names>Dharmarajan</given-names>
            </name>
            <name>
              <surname>Kantevari</surname>
              <given-names>Srinivas</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Click-based synthesis and antitubercular evaluation of novel dibenzo[ b , d ]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages</article-title>
          <source>Bioorganic &amp; Medicinal Chemistry Letters</source>
          <year>2016</year>
          <volume>26</volume>
          <issue>11</issue>
          <fpage>2649</fpage>
          <lpage>2654</lpage>
          <issn>0960-894X</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.bmcl.2016.04.015</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794888">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Shu</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Zhi</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Chuan</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>Qing-Cheng C</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>Le</given-names>
            </name>
            <name>
              <surname>Lv</surname>
              <given-names>Zao-Sheng S</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>Lian-Shun S</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Triazole derivatives and their anti-tubercular activity</article-title>
          <source>European Journal of Medicinal Chemistry</source>
          <year>2017</year>
          <volume>138</volume>
          <fpage>501</fpage>
          <lpage>513</lpage>
          <issn>0223-5234</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.ejmech.2017.06.051</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794881">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ali</surname>
              <given-names>A A</given-names>
            </name>
            <name>
              <surname>Gogoi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chaliha</surname>
              <given-names>A K</given-names>
            </name>
            <name>
              <surname>Buragohain</surname>
              <given-names>A K</given-names>
            </name>
            <name>
              <surname>Trivedi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Saikia</surname>
              <given-names>P J</given-names>
            </name>
            <name>
              <surname>Gehlot</surname>
              <given-names>P S</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chaturvedi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sarma</surname>
              <given-names>D</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and biological evaluation of novel 1, 2, 3-triazole derivatives as anti-tubercular agents</article-title>
          <source>Bioorganic &amp; Medicinal Chemistry Letters</source>
          <year>2017</year>
          <volume>27</volume>
          <issue>16</issue>
          <fpage>3698</fpage>
          <lpage>3703</lpage>
          <uri>https://doi.org/10.1016/j.bmcl.2017.07.008</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794870">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>Sheng-Jiao J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Yong-Jiang J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Yu-Lan L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Lin J</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Jun</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>An efficient one-pot synthesis of heterocycle-fused 1,2,3-triazole derivatives as anti-cancer agents</article-title>
          <source>Bioorganic &amp; Medicinal Chemistry Letters</source>
          <year>2010</year>
          <volume>20</volume>
          <issue>17</issue>
          <fpage>5225</fpage>
          <lpage>5228</lpage>
          <issn>0960-894X</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.bmcl.2010.06.141</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794868">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagesh</surname>
              <given-names>Hunsur Nagendra</given-names>
            </name>
            <name>
              <surname>Suresh</surname>
              <given-names>Narva</given-names>
            </name>
            <name>
              <surname>Prakash</surname>
              <given-names>Gollapalli Venkata Subrahmanya Bhan</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>Samarth</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>Janapala Venkateswara</given-names>
            </name>
            <name>
              <surname>Sekhar</surname>
              <given-names>Kondapalli Venkata Gowri Chandra</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and biological evaluation of novel phenanthridinyl piperazine triazoles via click chemistry as anti-proliferative agents</article-title>
          <source>Medicinal Chemistry Research</source>
          <year>2015</year>
          <volume>24</volume>
          <issue>2</issue>
          <fpage>523</fpage>
          <lpage>532</lpage>
          <issn>1054-2523</issn>
          <publisher-name>Springer Science and Business Media LLC</publisher-name>
          <uri>https://doi.org/10.1007/s00044-014-1142-6</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794853">
        <element-citation publication-type="misc">
          <person-group person-group-type="author">
            <name>
              <surname>Farooq</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Qurishi</surname>
              <given-names>M A</given-names>
            </name>
            <name>
              <surname>Hamid</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koul</surname>
              <given-names>S</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)</article-title>
          <source>Anticancer Agents Med Chem</source>
          <year>2018</year>
          <volume>18</volume>
          <fpage>1531</fpage>
          <lpage>1540</lpage>
          <uri>https://doi.org/10.2174/1871520618666171229222956</uri>
        </element-citation>
      </ref>
      <ref id="R218357329794891">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venkata</surname>
              <given-names>Sivarami Reddy Gangireddy</given-names>
            </name>
            <name>
              <surname>C.Narkhede</surname>
              <given-names>Umesh</given-names>
            </name>
            <name>
              <surname>Jadhav</surname>
              <given-names>Vinod. D</given-names>
            </name>
            <name>
              <surname>Naidu</surname>
              <given-names>Challa Gangu</given-names>
            </name>
            <name>
              <surname>Addada</surname>
              <given-names>Ramakrishnam Raju</given-names>
            </name>
            <name>
              <surname>Pulya</surname>
              <given-names>Sravani</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>Balaram</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Quinoline Consists of 1H‐1,2,3‐Triazole Hybrids: Design, Synthesis and Anticancer Evaluation</article-title>
          <source>ChemistrySelect</source>
          <year>2019</year>
          <volume>4</volume>
          <issue>48</issue>
          <fpage>14184</fpage>
          <lpage>14190</lpage>
          <issn>2365-6549</issn>
          <publisher-name>Wiley</publisher-name>
          <uri> https://doi.org/10.1002/slct.201903938</uri>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
